In its annual fall report dedicated to oncology, Prime Therapeutics highlights strategies to improve outcomes, reduce costs and support patients — starting with a bold approach to managing cancer care

New continuing education course showcases her expertise in biomarker testing and targeted therapy for EGFR-mutated NSCLC

Report features new highlights and rankings of the top 50 drug classes by percent of net spend.

Certification recognizes quality service and continuous improvement